www.bna.com Product Safety & Liability Reporter: Current Reports
HomeIndexTable of CasesFeedbackwww.bna.com

Printable version (PDF) 

INDEX
Vol. 36, Nos. 1-42, pp. 1-1080
Jan. 7 -- Oct. 27, 2008

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

    DAMAGES
      See also PUNITIVE DAMAGES
      – Accutane as cause of inflammatory bowel disease, woman awarded compensatory damages (N.J. Super. Ct.), 439
      – Air ambulance helicopter crash, parties settle for $18.4M (Neb. Dist. Ct.), 441
      – Asbestos
        – – Aerospace sealants and parts, future noneconomic damages vacated as excessive, review denied (Cal.), 237
        – – Automotive parts warehouse worker, jury award to widow (N.J. Super. Ct.), 259
      – Bisphenol-A class actions, Analysis and Perspective, 1006
      – Brakes, Kia Sephia owners awarded $6M (N.J. Super. Ct.), 595
      – Hearing devices, finding of no preemption reversed (Ark.), 392
      – Heparin, consolidation motion set (J.P.M.L.), 494; panel transfers suits (N.D. Ohio), 579; retired nurse and husband sue Baxter alleging harm, 647
      – HRT as cause of breast cancer, compensatory damages awarded (E.D. Ark.), 205; jury awards punitive damages, 260; punitive award vacated, 659
      – Mitsubishi SUV rollover, maker to appeal award to parents of ejected man (Fla. Cir. Ct.), 259
      – Motorcycles tire failure, $15M jury award upheld despite not showing exact cause of defect (C.D. Ill.), 574
      – Ohio statute of repose constitutional but doesn't apply to pre-effective date injury (Ohio), 234
      – Parlodel, woman died of seizure, compensatory award affirmed, causation proof properly admitted (Ky.), 491
      – Seating collapse caused death, award thrown out due to jury instruction error (Ill.), 1052
      – Spinal implant discs, suit alleges maker failed to follow FDA approval process (S.D. Tex.), 263; improper venue dismissal argument rejected, 451; plaintiff allowed to take discovery related to clinical trials, 579; venture capital firm remains defendant, 691
      – Truck aftermarket finisher responsible for safety device not Ford (N.J. Super. Ct.), 310
      – Vioxx
    DAUBERT CRITERIA
      – Bridgestone/Firestone, nylon cap theory disallowed (D.N.M.), 897
      – House fire allegedly caused by microwave oven, dismissing experts went beyond Daubert (Vt.), 203
      – Ladders, rivet improperly stamped, jury verdict approved after evidence review (E.D. Wis.), 519
      – Parlodel, woman died of seizure, compensatory award affirmed, causation proof properly admitted (Ky.), 491
      – Polio vaccine allegedly caused brain cancer, defense judgment upheld (3d Cir.), 899
      – Pool cleaner, no loss of smell evidence, medical testimony barred (E.D. Tenn.), 647
      – Rear liftgate, repair instructions and warning fall within engineer's expertise (3d Cir.), 330
      – Skid loaders, defect suit reinstated, expert improperly excluded (Ind. Ct. App.), 581
      – Viagra MDL, plaintiffs and Pfizer file motions (D. Minn.), 6; some experts allowed, other excluded, 394
    DECONGESTANTS
      – Cold-Eeze, case properly dismissed, siblings fail to link zinc to loss of smell (8th Cir.), 846
      – Methamphetamine activity, makers cannot be held liable (E.D. Ark.), 189
      – OTC medicines, FDA says not for use by children under 2 years old, 93; industry updating labels to ensure safety, Public Citizen tells FDA to ban for children under 12, 991
    DEFECT INVESTIGATIONS
    DEFENSES
      – Economic loss doctrine, Subaru fuel line repair claims tossed (D.N.J.), 287
      – Government contractors
        – – Agent Orange, U.S. veterans and Vietnamese cannot seek damages (3d Cir.), 207
        – – Asbestos, Navy aircraft parts makers lose removal (D. Mass.), 60
      – Independent knowledge, surgical cutting/stapling device maker not liable for failure to warn when doctor aware of risk (Tex. Ct. App.), 34
      – Learned intermediary doctrine
      – “Open and obvious” and “incurred risk,” accident involving rebuilt crane, defense verdict upheld (7th Cir.), 88
      – Physicians' prescribing practices
        – – Cymbalta, warning claim rejected when doctor would have prescribed anyway (E.D. La.), 521
        – – Effexor, widow's claims barred (5th Cir.), 445
        – – Hormone replacement therapy as cause of breast cancer, N.J. woman to appeal causation decision (Pa. Ct. C.P.), 61
        – – Paxil wrongful death suit, family seeks reversal of defense judgment (D. Kan.), 111
      – Reasonably anticipated uses, express warnings protect maker in heat therapy pad lawsuit (5th Cir.), 188
      – Sophisticated user rule applies, AC equipment technician's phosgene gas exposure claim dismissed (Cal.), 328
      – Unforeseeable misuse, plaintiffs' expert allowed to testify in pool chlorine feeder explosion suit (Ohio Ct. App.), 65
    DEFIBRILLATORS
      – Battery flaw MDLs
        – – Guidant, settlement fund established (D. Minn.), 10; some attorneys oppose fee request, 170; attorneys' fees dispute resolved, 189; court adopts procedures for common fund attorneys' fees, 265; court explains decision, 288; reconsideration request denied, 337
        – – Medtronic announces settlement (D. Minn.), 10; date set for common benefit attorneys' fees hearing, 627; remaining claims transferred, dismissal request denied when preemption unclear at this stage (N.D. Ill.), 900
      – Canada
        – – Guidant, class action approved (Ontario Super. Ct.), 417
        – – Riata leads, class alleges design flaw (Ontario Super. Ct.), 418
      – Maximo model 7278, preemption ruling controls defect case (D. Minn.), 800
      – Sprint Fidelis leads, consolidation sought (J.P.M.L.), 30; consolidation granted, 209; wrongful death suit transferred (E.D. Tex.), 958
      – Statutes of limitations, widow's suit dismissed on timeliness grounds (N.D. Miss.), 471
    DELAWARE
      – Sutures, loss of allegedly defective suture does not count against plaintiff (Del. Super. Ct.), 239
    DES
    DIABETES DRUGS
      – Avandia
      – Nonusers, company had no duty to warn (Md.), 870
      – Synthetic insulin allegedly caused cancer, learned intermediary principles bar suit (D.P.R.), 989
    DIET DRUGS
      – Body wrap weight-loss treatment, woman's health claims not time-barred (E.D. Cal.), 1056
      – Ephedra suit remanded on question of medical knowledge (2d Cir.), 821
      – Medical malpractice claim timely (E.D. Pa.), 825
      – Pharmacy dispensed recalled drug, customer may assert negligence claims (Utah), 924
      – Pondimin
        – – Repose law bars claim before accrual (E.D. Tenn.), 311
        – – Wrongful death claim rejected (Pa. C.P.), 1023
      – PPA distributor not “seller” entitled to immunity (N.J. Super. Ct.), 597
      – Redux, wrongful death claims dismissed, PPH warning legally adequate (N.D. Ohio), 238
    DIETHYLSTILBESTROL (DES)
      – Transfer to Mass. granted (D.D.C.), 622
    DIGITEK
      – MDL, oral arguments set on centralization (J.P.M.L.), 623; suits consolidated (S.D.W.Va.), 805
      – Minn. man sues drug makers alleging cause of digitalis toxicity (D. Minn.), 878
    DISCLOSURE
      – Explorer rollover, documents under protective order may not be disclosed to other litigants (Mo.), 4
      – Perclose suturing device, defense judgment not precluded for non-preempted claim (Kan.), 626
      – Seroquel MDL, disclosure ordered of documents used to prep witness (M.D. Fla.), 142; plaintiffs appeal order allowing defense to contact and retain doctors, 416
    DISCOVERY
      – Air bags, expert evidence needed to establish causation (N.Y. App. Div.), 664
      – Benlate, recovery in fraudulent inducement to settle case blocked (U.S., rev den), 415
      – Benzene, request over broad so prohibited in wrongful death suit (Tex. App. Ct.), 805
      – Bextra and Celebrex MDL, request for peer-review journal article documents denied (N.D. Ill.), 313; another court denies request for documents (D. Mass.), 369; settlement announced (N.D. Cal.), 1053
      – Bowflex machines, Nautilus moves class action to federal court (Ark.), 113
      – Child safety, foreign maker accountability, Analysis and Perspective, 219
      – Crash-test documents, sanction for refusal to produce and award approved (Ga.), 329
      – Drug-eluting stent, discovery sharing request rejected (Fla. Dist. Ct.), 774
      – Ford Explorer rollover
        – – Protective order, documents may not be disclosed to other litigants (Mo.), 4
        – – Settlement, family may pursue fraud claim (5th Cir.), 776
      – Spinal implant discs, plaintiff allowed to take discovery related to clinical trials (S.D. Tex.), 579; venture capital firm remains defendant, 691
      – Surgical stapler, failure to identify defeats second motion to compel (N.D. Ga.), 66
    DISTRICT OF COLUMBIA
      – Alcoholic energy drinks, MillerCoors sued over deceptive advertising directed at youth (D.C.), 894
      – Anthrax Vaccine Adsorbed, FDA made no clear error of judgment in approving (D.D.C.), 287
    DOG FOOD
    DOOR LATCHES
      – Daimler Smart car
        – – New Car Assessment Program, good score with ejection warning, 343
        – – Ratings good but door unlatches, IIHS test, 509
      – Ford recalls Expedition and Lincoln Navigator SUVs, 177
      – Handles, consumer harm from noncompliance recognized (Mass.), 594
    DOORS
      – Defect investigations, NHTSA, 274; 587; 652; 696
      – Rear Liftgate bolts, Subaru recalls Impreza wagons, 345
    DRUGS
      – Adverse event reporting system (AERS), FDA to post reports quarterly on Web, 879
      – Anti-seizure drugs, pre-service removal allowed (N.D. W. Va.), 822
      – Antibiotics
      – Antidepressants, positive studies more likely to be published, 117
      – Antiepileptic drugs, FDA warns of increased suicide risk, 172
      – Aredia and Zometa MDL, Mich. plaintiffs' claims dismissed due to immunity law and preemption (M.D. Tenn.), 372; Tex. plaintiffs' claims dismissed (M.D. Tex.), 731
      – Bextra and Celebrex MDL, request for peer-review journal article documents denied (N.D. Ill.), 313; another court denies request for documents (D. Mass.), 369; settlement announced (N.D. Cal.), 1053
      – Botox
      – China, CRS report cites economic implications of product safety and quality concerns, 69
      – Clinical trial oversight, GOP lawmaker's ask GAO to investigate, 291
      – Colchicine, learned intermediary doctrine bars claims against hospital and pharmacist (Ala.), 265
      – Cold remedies
      – Compound medications, new trial ordered on warranty claim against pharmacist (Fla. Ct. App.), 32
      – Contraceptives
      – Country of origin labeling
        See LEGISLATION, FEDERAL, S 3633
      – Cymbalta, warning claim rejected when doctor would have prescribed anyway (E.D. La.), 521
      – Digitek
        – – MDL, oral arguments set on centralization (J.P.M.L.), 623; suits consolidated (S.D.W.Va.), 805
        – – Minn. man sues drug makers alleging cause of digitalis toxicity (D. Minn.), 878
      – Effexor, widow to appeal whether suicide warning claim barred (W.D. Okla.), 82
      – Elidel, parents of toddler unable to prove drug caused lymphoma (E.D. Pa.), 685
      – Erythropoiesis-stimulating agents, FDA announces revised warnings and label changes, 266; advisers recommend restrictions and patient consent, 316
      – FDA Globalization Act, House Democrats release draft bill to improve drug and device import safety, 420; FDA says risk assessment should determine inspection priorities, 457
      – Fentanyl
      – Food and Drug Administration Amendments Act
      – Foreign drug inspection program, GAO reports improvements needed, industry group agrees, 1063
      – Fosamax MDL, certification denied for three state medical monitoring classes (S.D.N.Y.), 63
      – Generic drugs
      – Global safety initiative, HHS Leavitt calls for, 525
      – Heparin
      – Hormone replacement therapy
      – Importer bonds
        See LEGISLATION, FEDERAL, HR 5069, S 2081
      – Infant cough and cold drugs
      – Inspections, HHS announces pilot project with EU and Australia, 671
      – Labeling
        – – FDA proposal reaffirms position on “changes being effected” supplements, 66; Democrats question proposal, 92; withdrawal of rule urged, 241; trial lawyer group critical, says contradicts congressional intent, 289; FDA official grilled at preemption hearing, 497; House Oversight Comm. seeks FDA documents showing stance on preemption, 667; FDA finalizes rule, 827
        – – Preemption of state claims
      – Levaquin, moving nonresidents' claims to home states inconvenient (D. Minn.), 314; suits consolidated, 626
      – Lipitor, Ga. proper forum for Ga. man's suit (N.Y. Sup. Ct.), 646
      – Lotensin, claim that drug needed pregnancy hazard warning preempted (W.D.N.C.), 332
      – MDL
      – Metoclopramide
      – Motrin allegedly caused blindness, Johnson & Johnson exonerated (Cal. Super. Ct.), 735
      – Oversight improvements
        See LEGISLATION, FEDERAL, S 3409
      – OxyContin, judgment to maker, unable to prove drug caused addiction (W.D.W.Va.), 988
      – Pain pumps, degeneration of shoulder cartilage
        – – Continued use, Kan. woman alleges use not design unsafe (D. Minn.), 877
        – – Drug companies also sued (D. Ore., D. Minn.), 338
        – – Makers marketed use of device as safe (D. Minn., S.D. Ind.), 338; oral arguments set on centralization (J.P.M.L.), 623; Ariz. woman files suit (D. Ariz.), 625; transfer and centralization denied (J.P.M.L.), 804
      – Parlodel, woman died of seizure, compensatory award affirmed, causation proof properly admitted (Ky.), 491
      – Paxil
      – Pergolide allegedly causes heart disease, risks understated (D. Minn.), 736
      – Phenergan
      – Pondimin, repose law bars claim before accrual (E.D. Tenn.), 311
      – Prozac, better warning would not alter prescription (N.D. Ga.), 261
      – Redux, wrongful death claims dismissed, PPH warning legally adequate (N.D. Ohio), 238
      – Remicade, three defendants not “sellers” under N.J. law, remand motion denied (D.N.J.), 715
      – Safety information, FDA launches new Web page, 1031
      – Side effects, FDA advisory panel says to include hotline in TV ads, 526
      – Smoking cessation product, Pfizer updates Chantix label to include behavior changes, 118
      – Trasylol
      – Viagra
      – Vioxx
      – Vytorin and Zetia suits consolidated (D. N.J.), 399
      – Zyprexa
    DUE PROCESS
      – Bridgestone/Firestone tire defect suit, sanction against expert set aside (7th Cir.), 690
      – Bumbo Baby Sitter, personal jurisdiction found over S. African maker (N.D . Cal.), 548
      – Ceiling fans, Ill. court lacks jurisdiction over Taiwanese maker (Ill. App. Ct.), 107
      – Ga. expert admissibility rules constitutional, exclusion in floor-covering case affirmed (Ga.), 281
      – Ladders, Tenn. long-arm statute does not extend to German maker (6th Cir.), 928
      – Lead paint public nuisance suits
        – – Municipalities, various rulings, 640
        – – R.I. suit, paint makers appeal verdict, argue cumulative nuisance unconstitutional (R.I.), 163; amicus brief filed, 165; Webcast of oral arguments offered, 470; suit rejected, claims fall outside public nuisance law, 640; Analysis and Perspective, 834
      – Motor vehicles, offset collisions, DaimlerChrysler liability upheld but punitive award reduced (Tenn. Ct. App.), 1020
      – Ortho Evra patch MDL, state caps on noneconomic and punitive damages withstand constitutional challenges (Ohio), 28
      – Punitive damages, harm to nonparties, Philip Morris
        – – Cal. $25M award tossed (Cal.), 136; (rev den), 471
        – – Ore., Marlboro cigarettes, large award reaffirmed (Ore.), 135; whether state supreme court may interpose state-law procedural bar (U.S., rev grant), 575; (oral arg set), 959
      – Radiation therapy devices, case dismissed for lack of personal jurisdiction over maker (5th Cir.), 371
      – Stucco defective, full faith and credit governs case of plaintiff who didn't opt out of settlement (N.J.), 803
      – Tobacco-related illnesses, findings from predecessor smoking class rejected without enforceable judgment (M.D. Fla.), 843

Contact the Webmaster at webmaster@bna.com
1801 S. Bell Street, Arlington, VA 22202 - Phone: 1-800-372-1033

Copyright © The Bureau of National Affairs, Inc. All Rights Reserved.